Bittium Corporation: Notification of Manager’s Transactions
Stock Exchange Release
Free for publication on May 17, 2021 at 2.30 p.m. (CEST+1)
Bittium Corporation: Notification of Manager’s Transactions
Person subject to the notification requirement
Name: Riitta Tiuraniemi
Position: Member of the Board of Directors
Notification type: Initial Notification
Reference number: 743700NFG5W5I59OVX65_20210514091431_2
Issuer: Bittium Corporation
LEI: 743700NFG5W5I59OVX65
Transaction date: May 12, 2021
Venue: XHEL
Instrument: Share
ISIN: FI0009007264
Nature of transaction: Receipt of a Share-Based Incentive
Transaction details
- Volume: 132, unit price: 6.66000 EUR
- Volume: 34, unit price: 6.65000 EUR
- Volume: 121, unit price: 6.64000 EUR
- Volume: 134, unit price: 6.62000 EUR
- Volume: 150, unit price: 6.62000 EUR
- Volume: 150, unit price: 6.62000 EUR
- Volume: 150, unit price: 6.62000 EUR
- Volume: 83, unit price: 6.62000 EUR
- Volume: 274, unit price: 6.51000 EUR
- Volume: 24, unit price: 6.51000 EUR
- Volume: 28, unit price: 6.51000 EUR
- Volume: 24, unit price: 6.51000 EUR
- Volume: 8, unit price: 6.51000 EUR
- Volume: 193, unit price: 6.42000 EUR
Aggregated transactions
Volume: 1,505
Volume weighted average price: 6.57398 EUR
Oulu, May 17, 2021
Hannu Huttunen
CEO
Further information:
Kari Jokela
Chief Legal Officer
Tel. +358 40 344 5258
Distribution
Nasdaq Helsinki Oy
Main media
Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com